ABC Cencora Inc.


$ 337.81 $ 0.00 (0 %)    

Monday, 03-Nov-2025 04:52:15 EST
QQQ $ 633.07 $ 0.00 (0 %)
DIA $ 476.16 $ 0.00 (0 %)
SPY $ 684.73 $ 0.00 (0 %)
TLT $ 90.00 $ 0.00 (0 %)
GLD $ 367.83 $ 0.00 (0 %)
$ 337.81
$ 339.92
$ 318.00 x 5
$ 342.50 x 1
-- - --
$ 222.57 - $ 350.46
1,279,463
na
na
$ 0.50
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tivic-to-offer-sinus-pain-relief-device-in-retail-pharmacy-marketplace-via-amerisourcebergens-platform

Tivic Health Systems, Inc. (NASDAQ: TIVC)

Core News & Articles

Tivic Health® Systems, Inc. (("Tivic", "Company", NASDAQ:TIVC), a health tech company that develops and commerc...

Core News & Articles

-Walll Street Journal

Core News & Articles

TD Cowen analyst Charles Rhyee maintains AmerisourceBergen (NYSE:ABC) with a Outperform and raises the price target from $20...

Core News & Articles

Transaction Highlights Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation pursuant to pr...

Core News & Articles

Morgan Stanley analyst Ricky Goldwasser maintains AmerisourceBergen (NYSE:ABC) with a Equal-Weight and raises the price targ...

 amerisourcebergen-lifts-2023-forecast-on-higher-demand-for-weight-loss-and-diabetes-products-cushioning-lower-covid-19-sales

Drug distributor AmerisourceBergen Corporation's (NYSE: ABC) Q3 FY23 adjusted EPS reached $2.92, up 11.5% Y/Y, beating the 

 earnings-scheduled-for-august-2-2023

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

Core News & Articles

AmerisourceBergen (NYSE:ABC) reported quarterly earnings of $2.92 per share which beat the analyst consensus estimate of $2.83 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION